Connection

Andrea Isidori to Hydrocortisone

This is a "connection" page, showing publications Andrea Isidori has written about Hydrocortisone.
Connection Strength

1.459
  1. Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection. Lancet Diabetes Endocrinol. 2020 06; 8(6):472-473.
    View in: PubMed
    Score: 0.393
  2. Once-daily, modified-release hydrocortisone in patients with adrenal insufficiency - Authors' reply. Lancet Diabetes Endocrinol. 2018 04; 6(4):270-271.
    View in: PubMed
    Score: 0.341
  3. Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas. Eur J Endocrinol. 2018 May; 178(5):501-511.
    View in: PubMed
    Score: 0.339
  4. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial. Lancet Diabetes Endocrinol. 2018 03; 6(3):173-185.
    View in: PubMed
    Score: 0.334
  5. Recovery of the Hypothalamo-Pituitary-Adrenal Axis After Transsphenoidal Adenomectomy for Non-ACTH-Secreting Macroadenomas. J Clin Endocrinol Metab. 2019 11 01; 104(11):5316-5324.
    View in: PubMed
    Score: 0.024
  6. Mortality data from the European Adrenal Insufficiency Registry-Patient characterization and associations. Clin Endocrinol (Oxf). 2018 07; 89(1):30-35.
    View in: PubMed
    Score: 0.021
  7. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome? Clin Endocrinol (Oxf). 2000 Oct; 53(4):493-500.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.